My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 124

    1.

    Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy?

    Giusti C, Schiaffini R, Bosco D, Ciampalini P, Pantaleo A, Vingolo EM, Gargiulo P.

    Br J Ophthalmol. 2000 May;84(5):531-3.PMID: 10781520 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.

    Gargiulo P, Schiaffini R, Bosco D, Ciampalini P, Pantaleo A, Romani B, Arcieri P, Andreani D.

    Diabet Med. 1997 Feb;14(2):132-7.PMID: 9047090 [PubMed - indexed for MEDLINE]Related articles

    3.

    Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients.

    Giusti C, Schiaffini R, Brufani C, Pantaleo A, Vingolo EM, Gargiulo P.

    Br J Ophthalmol. 2000 Jun;84(6):591-5.PMID: 10837382 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Enhanced anticoagulant response to activated protein C in patients with IDDM.

    Krugluger W, Kopp HP, Schernthaner G, Hopmeier P.

    Diabetes. 1995 Sep;44(9):1033-7.PMID: 7657025 [PubMed - indexed for MEDLINE]Related articles

    5.

    Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.

    Pötzsch B, Kawamura H, Preissner KT, Schmidt M, Seelig C, Müller-Berghaus G.

    J Lab Clin Med. 1995 Jan;125(1):56-65.PMID: 7822946 [PubMed - indexed for MEDLINE]Related articles

    6.

    Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.

    Nojima J, Kuratsune H, Suehisa E, Kawasaki T, Machii T, Kitani T, Iwatani Y, Kanakura Y.

    Br J Haematol. 2002 Aug;118(2):577-83.PMID: 12139749 [PubMed - indexed for MEDLINE]Related articles

    7.

    Plasma prekallikrein as a risk factor for diabetic retinopathy.

    Kedzierska K, Ciechanowski K, Gołembiewska E, Safranow K, Ciechanowicz A, Domański L, Myślak M, Róźański J.

    Arch Med Res. 2005 Sep-Oct;36(5):539-43.PMID: 16099335 [PubMed - indexed for MEDLINE]Related articles

    8.

    Protein C activation in NIDDM patients.

    Gabazza EC, Takeya H, Deguchi H, Sumida Y, Taguchi O, Murata K, Nakatani K, Yano Y, Mohri M, Sata M, Shima T, Nishioka J, Suzuki K.

    Diabetologia. 1996 Dec;39(12):1455-61.PMID: 8960826 [PubMed - indexed for MEDLINE]Related articles

    9.

    Increased activated protein C-protein C inhibitor complex level in patients positive for lupus anticoagulant.

    Nakase T, Wada H, Minamikawa K, Wakita Y, Shimura M, Hiyoyama K, Tamaki S, Shirakawa S, Deguchi K, Nisioka J, et al.

    Blood Coagul Fibrinolysis. 1994 Apr;5(2):173-7.PMID: 8054449 [PubMed - indexed for MEDLINE]Related articles

    10.

    The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.

    Di Mario U, Borsey DQ, Contreas G, Prowse CV, Clarke BF, Andreani D.

    Clin Exp Immunol. 1986 Jul;65(1):57-65.PMID: 2947762 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Fibrinogen plasma levels as a marker of thrombin activation in diabetes.

    Ceriello A, Taboga C, Giacomello R, Falleti E, De Stasio G, Motz E, Lizzio S, Gonano F, Bartoli E.

    Diabetes. 1994 Mar;43(3):430-2.PMID: 8314016 [PubMed - indexed for MEDLINE]Related articles

    12.

    Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.

    Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y.

    Clin Chem. 2005 Mar;51(3):545-52. Epub 2005 Jan 6.PMID: 15637132 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients.

    Molino D, De Santo NG, Marotta R, Anastasio P, Mosavat M, De Lucia D.

    Semin Nephrol. 2004 Sep;24(5):495-501.PMID: 15490419 [PubMed - indexed for MEDLINE]Related articles

    14.

    Development and progression of diabetic retinopathy in patients with Type 1 diabetes who are positive for GAD autoantibody.

    Mimura T, Funatsu H, Uchigata Y, Kitano S, Shimizu E, Noma H, Amano S, Araie M, Iwamoto Y, Hori S.

    Diabet Med. 2004 Jun;21(6):559-62.PMID: 15154939 [PubMed - indexed for MEDLINE]Related articles

    15.

    Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus.

    Gargiulo P, Goldberg J, Romani B, Schiaffini R, Ciampalini P, Faulk WP, McIntyre JA.

    Clin Exp Immunol. 1999 Oct;118(1):30-4.PMID: 10540156 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy.

    Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Slama G, Reach G, Selam JL.

    Diabetologia. 2002 Mar;45(3):436-42.PMID: 11914750 [PubMed - indexed for MEDLINE]Related articles

    17.

    Determination of activated protein C resistance in anticoagulated and lupus positive patients.

    Ivey LM, Thom JY, Ivey JG, Baker RI.

    Blood Coagul Fibrinolysis. 2000 Jul;11(5):439-45.PMID: 10937805 [PubMed - indexed for MEDLINE]Related articles

    18.

    The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.

    Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J.

    Blood. 2004 Jul 1;104(1):143-8. Epub 2004 Mar 16.PMID: 15026314 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A comparison of the levels of hepatocyte growth factor in serum in patients with type 1 diabetes mellitus with different stages of diabetic retinopathy.

    Nowak M, Wielkoszyński T, Marek B, Kos-Kudła B, Swietochowska E, Siemińska L, Kajdaniuk D, Głogowska-Szelag J, Nowak K.

    Endokrynol Pol. 2008 Jan-Feb;59(1):2-5.PMID: 18335393 [PubMed - indexed for MEDLINE]Related articles

    20.

    Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus.

    Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Kitani T, Iwatani Y, Kanakura Y.

    Br J Haematol. 2001 Sep;114(3):647-54.PMID: 11552993 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity